Drug Type Small molecule drug |
Synonyms RGB 286638 |
Target |
Action inhibitors |
Mechanism CDK inhibitors(Cyclin-dependent kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H36ClN7O4 |
InChIKeyYGFQVIOJTIQVTO-UHFFFAOYSA-N |
CAS Registry784210-87-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Phase 1 | United States | 26 Aug 2022 | |
| Chronic Lymphocytic Leukemia | Phase 1 | - | 01 Nov 2011 | |
| Chronic Myelogenous Leukemia | Phase 1 | - | 01 Nov 2011 | |
| Small Lymphocytic Lymphoma | Phase 1 | - | 01 Nov 2011 |





